Since its foundation in 1929 by Henri Beaufour, Ipsen has made a wide range of products in Consumer Healthcare, Oncology, Neuroscience and Rare Diseases available to patients. Learn more about the development of the group; our global footprint, acquisitions, partnerships, scientific collaborations and innovations.

Early 2017: Acquisition of oncology assets from Merrimack Pharmaceuticals, a major step forward in bolstering Ipsen’s growing oncology presence and leveraging its oncology infrastructure in the United States.
Read more
Last update 17/11/2017